SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
118 views 1234 days ago -
Watch Later
34:00Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?
198 views 1490 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
195 views 1236 days ago -
Watch Later
!["Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH]()
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
181 views 1194 days ago -
Watch Later
!["Updates in Adult Minimal Change Disease" presented by Ruth Campbell]()
51:21"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
214 views 1216 days ago -
Watch Later
!["Updates in IgA Nephropathy" presented by Natalie Beck, MD]()
58:12"Updates in IgA Nephropathy" presented by Natalie Beck, MD
223 views 1216 days ago -
Watch Later
!["Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell]()
37:35"Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell
231 views 1216 days ago
